Strengthened Interficial Adhesive Fracture Energy by Young's Modulus Matching Degree Strategy in Carbon-Based HTM Free MAPbI3 Perovskite Solar Cell with Enhanced Mechanical Compatibility

Carbon-based hole transport layer-free perovskite solar cells (PSCs) based on methylammonium lead triiodide (MAPbI3 ) have become one of the research focus due to low cost, easy preparation, and good optoelectronic properties. However, instability of perovskite under vacancy defects and stress-strain makes it difficult to achieve high-efficiency and stable power output. Here, a soft-structured long-chain 2D pentanamine iodide (abbreviated as "PI") is used to improve perovskite quality and interfacial mechanical compatibility. PI containing CH3 (CH2 )4 NH3 + and I- ions not only passivate defects at grain boundaries, but also effectively alleviate residual stress during high temperature annealing via decreasing Young's modulus of perovskite film. Most importantly, PI effectively increases matching degree of Young's modulus between MAPbI3 (47.1 GPa) and carbon (6.7 GPa), and strengthens adhesive fracture energy (Gc ) between perovskite and carbon, which is helpful for outward release of nascent interfacial stress generated under service conditions. Consequently, photoelectric conversion efficiency (PCE) of optimal device is enhanced from 10.85% to 13.76% and operational stability is also significantly improved. 83.1% output is maintained after aging for 720 h at room temperature and 25-60% relative humidity (RH). This strategy of regulation from chemistry and physics provides a strategy for efficient and stable carbon-based PSCs.

[A case of metastatic breast cancer complicated by pulmonary tumor thrombotic microangiopathy]

Pulmonary tumor thrombotic microangiopathy is a malignancy-related complication with rapid progression and high mortality. To improve the understanding of the disease, early diagnosis and treatment are key to successful treatment. A 39-year-old patient with pulmonary hypertension transferred from another hospital was admitted to the First Affiliated Hospital of Guangzhou Medical University on September 26, 2021. The patient developed shortness of breath and progressive exacerbation over the past month. No pulmonary artery embolism was seen on computed tomography pulmonary angiography (CTPA) at the outside hospital where the breast cancer was diagnosed. Pulmonary tumor thrombotic microangiopathy was immediately considered on admission and oncological endocrine therapy was started. After treatment, the patient's dyspnoea improved, PET-CT showed significant tumor regression, and cardiac ultrasound showed a significant decrease in pulmonary artery pressure. The successful treatment experience of this case was summarized for reference.

Treatment of silicosis with hepatocyte growth factor-modified autologous bone marrow stromal cells: a non-randomized study with follow-up

Pulmonary silicosis is an irreversible and untreatable disease that is characterized by interstitial lesions and perpetual fibrosis in the lungs. This study was performed to determine whether mesenchymal stem cells (MSCs) and hepatocyte growth factor (HGF) could exhibit therapeutic effects on human silicosis. This non-randomized uncontrolled trial comprised four patients with pulmonary silicosis who had developed lung fibrosis and received autologous bone marrow MSCs previously transfected by a vector containing human HGF cDNA (MSCs/HGF). MSCs/HGF were intravenously administered weekly for three consecutive weeks at a dose of 2 x 10(6) cells/kg. Pulmonary function, high kilo-voltage chest X-ray radiography, computed tomography (CT) scan, and peripheral blood lymphocyte subset and serum IgG concentrations were evaluated after cell therapy. The treatment was found to be generally safe. Symptoms such as cough and chest distress gradually ameliorated at six months post-therapy, accompanied by the significant improvement of pulmonary function. The ratios of the peripheral CD4- and CD8- positive cell concentrations were increased (P < 0.05). Furthermore, the serum IgG levels in these patients were decreased and reached the normal range (P < 0.05). CT scans showed partial absorption of the nodular and reticulonodular lesions in the lungs during follow-up of at least 12 months. The effectiveness of this novel regimen observed in these patients suggests that a placebo-controlled clinical trial needs to be developed. This study carries trial registration No. NCT01977131 (ClinicalTrials.gov).

Detection of DNA strand breaks, DNA-protein crosslinks, and telomerase activity in nickel-transformed BALB/c-3T3 cells

Although nickel compounds are known carcinogens, the underlying carcinogenic mechanisms are not fully understood. The objective of this research was to determine if the genotoxic lesions of DNA strand breaks and DNA-protein crosslinks are present in nickel-transformed BALB/c-3T3 cells, and to further elucidate the potential carcinogenesis of insoluble and soluble nickel compounds through telomerase activity in nickel-transformed BALB/c-3T3 cell lines. DNA strand breaks, DNA-protein crosslinks and telomerase activity were investigated by single cell gel electrophoresis (comet assay), (125)I-postlabelling techniques, and the TRAP-silver staining assay, respectively. Results showed that both DNA strand breaks and DNA-protein crosslinks were present in nickel-transformed BALB/c-3T3 cells. However, the highest levels of DNA strand breaks and DNA-protein crosslinks were found in insoluble crystalline NiS-transformed cells and high levels of DNA strand breaks and DNA-protein crosslinks were also found in the transformed cells induced by two water-soluble NiCl(2) and NiSO(4) at moderate concentrations of cytotoxicity. These data suggest that these two genetic endpoints are useful biomarkers and are associated with cell transformation and carcinogensis of insoluble and soluble nickel compounds. Also, we found that the crystalline NiS- and NiCl(2)-transformed cells possessed a high telomerase activity. A weak telomerase was found in NiSO(4)-transformed cells. The results seem to indicate that in addition to crystalline NiS, some water-soluble nickel compounds such as NiCl(2) are also highly carcinogenic. These results may partly explain the cell transformation and relative carcinogenic potency of insoluble crystalline NiS, soluble NiCl(2), and NiSO(4).

Enols of amides. The effect of fluorine substituents in the ester groups of dicarboalkoxyanilidomethanes on the enol/amide and E-enol/Z-enol ratios. A multinuclei NMR study

Condensation of phenyl isocyanate substituted by 4-MeO, 4-Me, 4-H, 4-Br, and 2,4-(MeO)(2) with esters CH(2)(CO(2)R)CO(2)R', R = CH(2)CF(3), R' = CH(3), CH(2)CF(3), CH(CF(3))(2), or R = CH(3), R' = CH(CF(3))(2) gave 17 "amides" ArNHCOCH(CO(2)R)CO(2)R' containing three, six, or nine fluorines in the ester groups. X-ray crystallography of six of them revealed that compounds with > or =6 fluorine atoms exist in the solid state as the enols of amides ArNHC(OH)=C(CO(2)R)CO(2)R' whereas the ester with R = R' = CH(3) was shown previously to have the amide structure. In the solid enols, the OH is cis and hydrogen bonded to the better electron-donating (i.e., with fewer fluorine atoms) ester group. X-ray diffraction could not be obtained for compounds with only three fluorine atoms, i.e., R = CH(2)CF(3), R' = CH(3) but the (13)C CP-MAS spectra indicate that they have the amide structure in the solid state, whereas esters with six and nine fluorine atoms display spectra assigned to the enols. The solid enols show unsymmetrical hydrogen bonds and the expected features of push-pull alkenes, e.g., long C(alpha)=C(beta) bonds. The structure in solution depends on the number of fluorine atoms and the solvent, but only slightly on the substituents. The symmetrical systems (R = R' = CH(2)CF(3)) show signals for the amide and the enol, but all systems with R not equal R' displayed signals for the amide and for two enols, presumably the E- and Z-isomers. The [Enol I]/[Enol II] ratio is 1.6-2.9 when R = CH(2)CF(3), R' = CH(3), CH(CF(3))(2) and 4.5-5.3 when R = CH(3), R' = CH(CF(3))(2). The most abundant enol display a lower field delta(OH) and a higher field delta(NH) and assigned the E-structure with a stronger O-H.O=C(OR) hydrogen bond than in the Z-isomer. delta(OH) and delta(NH) values are nearly the same for all systems with the same cis CO(2)R group. The [Enols]/[Amide] ratio in various solvents follows the order CCl(4) > CDCl(3) > CD(3)CN > DMSO-d(6). The enols always predominate in CCl(4) and the amide is the exclusive isomer in DMSO-d(6) and the major one in CD(3)CN. In CDCl(3) the major tautomer depends on the number of fluorines. For example, in CDCl(3,) for Ar = Ph, the % enol (K(Enol)) is 35% (0.54) for R = CH(2)CF(3,) R' = CH(3), 87% (6.7) for R = R' = CH(2)CF(3), 79% (3.8) for R = CH(3), R' = CH(CF(3))(2) and 100% (> or =50) for R = CH(2)CF(3), R' = CH(CF(3))(2). (17)O and (15)N NMR spectra measured for nine of the enols are consistent with the suggested assignments. The data indicate the importance of electron withdrawal at C(beta), of intramolecular hydrogen bonding, and of low polarity solvents in stabilizing the enols. The enols of amides should no longer be regarded as esoteric species.

Effects of metabolites of benzo(a)pyrene on unschedule DNA synthesis in BALB/3T3 cell line

In order to explore the damage from metabolites of benzo(a)pyrene on DNA of mammalian cells, the effects of four metabolites of benzo(a)pyrene (anti-BPDE, syn-BPDE, 3-OH-BP and 9-OH-BP) on synthesis of DNA and unschedule DNA synthesis (UDS) in BALB/3T3 cells were assayed, by methods of single-labeling and double-labeling. The results showed that all of the four agents were able to increase the synthesis of DNA, but only three of them (apart from syn-BPDE) induced UDS in BALB/3T3 cells. The above indicates that the metabolites of benzo(a)pyrene are able to damage DNA in BALB/3T3 cells, and that this effect may be relative to the sterical structure of metabolites of benzo(a)pyrene.

Some lifestyle factors in human lung cancer: a case-control study of 792 lung cancer cases

In order to investigate the relationship between some lifestyle factors and lung cancer, a case-control study involving all lung cancer deaths registered in 1986 was performed. The results show that among males, 92.5% of the cases and 75.5% of controls were smokers, implying that cigarette smoking is a primary risk factor for lung cancer in males. By contrast, among females only 60.6% of the cases and 30.8% of the controls were smokers, implying factors other than cigarette smoking must be involved in the development of lung cancer in females. The risk of lung cancer in nonsmoking females was found to be unaffected by exposure to environmental tobacco smoke (ETS). A study of diet and eating habits showed that in males the risk of lung cancer was reduced by the intake of vegetables and fruits, but was significantly increased by a frequent intake of fried foods. The positive association between the intake of fried food and the risk of lung cancer could result from cooking practices and from inappropriate methods used in food preparation. No association can be demonstrated between the consumption of high protein or high fat diets, salty and smoked food items and the incidence of lung cancer. Thus, it is not likely that sufficient lung cancer inducing carcinogens can be generated through the intake of food. In addition, the positive association found to exist between the living index and the risk of lung cancer in females is consistent with the notion that coal smoke or cooking practices may generate sufficient indoor air pollutants to significantly increase the risk of lung cancer in females.

Study on DNA-protein crosslinks induced by chromate and nickel compounds in vivo with 125I-postlabelling assay

In an attempt to develop biomarkers of chromate and nickel exposure, we have used a rapid, simple and sensitive 125I-postlabelling assay to detect the formation of DNA-protein crosslinks (DPCs) in different tissues from male Sprague-Dawley rats exposed i.p. to potassium chromate (K2CrO4) and nickel chloride (NiCl2). The results demonstrated that 20 h after rats were injected i.p. with these agents, DPCs were observed in WBC, liver and kidney of rats treated with K2CrO4 in doses ranging from 10 to 40 mg/kg body wt. There was a dose-dependent relationship between chromate exposure and DPCs in WBC and liver, but no DPC increase was shown in lung. In the same way, DPCs were found in WBC and lung of rats treated with NiCl2 in doses ranging from 10 to 30 mg/kg in a dose-dependent manner. The formation of DPCs in different tissues was also observed following repeated exposure of rats to K2CrO4 and NiCl2 (10 mg/kg, i.p.) for 3 weeks. These results were similar with the single dose. It is indicated that chromate and nickel compounds possibly cause DNA or protein damage to form DPCs, suggesting DPCs might be useful as a biomarker for quantitative K2CrO4 and NiCl2 exposure and genotoxic lesions. In addition, WBC were shown to be more sensitive to chromate(VI) and nickel(II) induced DPCs than other targets. There were significant correlations between DPCs induced by K2CrO4 in WBC and liver, and by NiCl2 generated DPCs in WBC and lung, indicating that DPCs in WBC may be a good surrogate for some internal organs of humans exposed to chromate(VI) and nickel(II) compounds.